Teva donates potential coronavirus treatment to hospitals across the US
March 21, 2020
…Recently, Israel’s Health Ministry has approved multiple experimental treatments, and companies worldwide are attempting to determine what could be used to treat the deadly disease. Teva, the giant Israeli pharmaceutical company, has announced that it will donate more than six million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals across the United States, starting March 31. Over 10 million tablets are expected to be shipped within a month. The tablets are approved by US Food and Drug Administration (FDA) for the treatment of malaria, lupus erythematosus and rheumatoid arthritis. The tablets are currently under investigation to determine their efficacy against the coronavirus, and US government officials have asked for their immediate availability and use. READ MORE
TECH STARTUPS Hydroxychloroquine is found to be more effective and potent than chloroquine in vitro treatment of coronavirus, new study published by NIH shows New controlled clinical study conducted by doctors in France shows that Hydroxychloroquine cures 100% of coronavirus patients within 6 days of treatment (covidtrial.io) On March 16, we covered a story about new academic study that revealed over-the-counter anti-malaria med Chloroquine may be highly effective at treating coronavirus. The study presented by Thomas R. Broker, (Stanford PhD), James M. Todaro (Columbia MD), and Gregory J. Rigano, Esq., in consultation with Stanford University School of Medicine, UAB School of Medicine, and National Academy of Sciences researchers, shows that over the counter anti-malaria pills Chloroquine may be highly effective at treating coronavirus COVID-19.